179064-49-4

Basic information

• Product Name: 1-(2-Fluorophenyl)-4-oxocyclohexanecarboxylic acid
• Synonyms: 1-(2-Fluorophenyl)-4-oxocyclohexanecarboxylic acid
• CAS NO: 179064-49-4
• Molecular Formula: C13H13FO3
• Molecular Weight: 236.2389232
• Mol File: 179064-49-4.mol

Chemical Properties

• Boiling Point: 410.4±45.0 °C(Predicted)
• Appearance: /
• Density: 1.297±0.06 g/cm3(Predicted)
• PKA: 3.70±0.20(Predicted)
• CAS DataBase Reference: 1-(2-Fluorophenyl)-4-oxocyclohexanecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-Fluorophenyl)-4-oxocyclohexanecarboxylic acid(179064-49-4)
• EPA Substance Registry System: 1-(2-Fluorophenyl)-4-oxocyclohexanecarboxylic acid(179064-49-4)

Safety Data

• Hazardous Substances Data: 179064-49-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Roxithromycin is utilized as an antibiotic for the treatment of various bacterial infections. Its application is primarily due to its effectiveness in inhibiting protein synthesis in bacteria, which leads to the prevention of infection growth and spread. It is particularly effective against a wide range of gram-positive and gram-negative bacteria.
Used in Respiratory Tract Infections:
In the medical field, roxithromycin is used as a therapeutic agent for respiratory tract infections. Its application in this context is attributed to its ability to target and eliminate bacteria responsible for causing such infections.
Used in Skin and Soft Tissue Infections:
Roxithromycin is also employed as a treatment for skin and soft tissue infections. Its use in this area is due to its effectiveness in combating the bacteria that cause these types of infections and preventing their progression.
Used in Sexually Transmitted Diseases:
Additionally, roxithromycin is used in the treatment of sexually transmitted diseases. Its application in this context is a result of its broad-spectrum antibacterial properties, which make it suitable for targeting the bacteria responsible for various sexually transmitted infections.

Relevant articles and documents

Cyclohexane derivatives and their use as therapeutic agents

The present invention relates compounds of formula (I), wherein ring A is a phenyl or pyridyl ring; X represents a linker selected from the group consisting of formulae: (a), (b), (c), (d), and (e); and R1, R2, R3, R4, R5, R6, R7, R13, R14, R15, R16, R17, R21a and R21b are as defined herein. The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpetic neuralgia.